Shreeji Global FMCG IPO GMP Today: Price, Date, Details, And Latest Updates

The Shreeji Global FMCG IPO has caught investors’ attention as it opens for subscription on November 4, 2025, and closes on November 7, 2025. The IPO is a book-built issue worth ₹85 crore, comprising a fresh issue of 0.68 crore shares. Investors are closely tracking the Shreeji Global FMCG IPO GMP (Grey Market Premium) to gauge potential listing gains and market sentiment.

🔹 Shreeji Global FMCG IPO Details
IPO Open Date: November 4, 2025
IPO Close Date: November 7, 2025
Allotment Date: November 10, 2025
Listing Date: November 12, 2025
Exchange: NSE SME
Issue Size: ₹85.00 crore
Price Band: ₹120 – ₹125 per share
Lot Size: 1,000 shares
Retail Minimum Investment: ₹2,50,000 (2 lots)
HNI Minimum Investment: ₹3,75,000 (3 lots)

🔹 Shreeji Global FMCG IPO GMP Today
As of November 1, 2025 (04:00 PM), the Shreeji Global FMCG IPO GMP is ₹0. This means there is no premium or discount being offered in the grey market at the moment.

Considering the upper price band of ₹125, the expected listing price is around ₹125, suggesting 0% estimated listing gain. The current grey market activity indicates neutral investor sentiment, as no major movement has been recorded over the last few sessions.

However, investors should note that GMP trends can change rapidly, especially closer to the listing date. A positive market trend or strong subscription numbers can push the GMP higher in the final days.

🔹 About Shreeji Global FMCG Ltd.
Shreeji Global FMCG Ltd. operates in the fast-moving consumer goods (FMCG) sector, focusing on essential daily-use products. The company has a strong distribution network and is expanding its presence across multiple regions in India. With the growing demand for FMCG products and rising rural consumption, the company aims to strengthen its position through this IPO issue.

🔹 Shreeji Global FMCG IPO Review
While the IPO size is moderate, Shreeji Global FMCG’s focus on high-demand consumer goods could attract investor interest. However, since the GMP remains flat, retail investors should carefully evaluate the company’s fundamentals, financials, and market potential before applying.

Long-term investors might see value if the company delivers consistent earnings growth, whereas short-term traders looking for listing gains may need to wait for a positive GMP shift before subscribing.

🔹 Expected Listing & Outlook
The tentative listing date for the Shreeji Global FMCG IPO is November 12, 2025, on the NSE SME platform. Based on current data, the expected listing price is ₹125, with no immediate profit indication.

Investors should keep monitoring daily GMP updates for changes in sentiment. A surge in grey market activity closer to the closing date could signal improved listing prospects.

FAQs on Shreeji Global FMCG IPO GMP
Q1. What is the GMP of Shreeji Global FMCG IPO today?
 As of November 1, 2025, the Shreeji Global FMCG IPO GMP is ₹0, indicating no premium in the grey market.

Q2. What is the issue size of Shreeji Global FMCG IPO?
 The total issue size is ₹85 crore, consisting entirely of a fresh issue of 0.68 crore shares.

Q3. What is the Shreeji Global FMCG IPO price band?
 The IPO price band is set between ₹120 and ₹125 per share.

Q4. When will Shreeji Global FMCG IPO allotment be finalized?
 The IPO allotment date is expected to be November 10, 2025.

Q5. On which exchange will Shreeji Global FMCG IPO list?
 The shares will be listed on the NSE SME platform on November 12, 2025.

Q6. Is Shreeji Global FMCG IPO good to invest in?
 The IPO’s attractiveness depends on your investment goal. While the GMP shows neutral sentiment, long-term investors may consider it based on fundamentals and future growth potential.

Conclusion:
The Shreeji Global FMCG IPO GMP currently reflects stable but cautious investor sentiment. As the listing date approaches, market trends and subscription data will play a crucial role in determining its grey market movement and potential listing gains. Stay updated with daily GMP trends and analysis to make an informed investment decision.